Johns Hopkins University, Baltimore, Maryland.
University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham.
Arthritis Care Res (Hoboken). 2023 Nov;75(11):2379-2388. doi: 10.1002/acr.25137. Epub 2023 Jul 13.
Systemic sclerosis (SSc) is associated with several specific risk factors for fracture due to the complications of the disease and related medications. The present study was undertaken to examine the relationship between SSc-associated clinical features and fracture rate in a large US cohort.
Participants with SSc in FORWARD, The National Databank for Rheumatic Diseases, were included (1998-2019). Age- and sex-matched individuals with osteoarthritis (OA) from the same database were included as comparators. The primary end point was self-reported major osteoporotic fracture. Cox proportional hazards models were used to study the associations between risk factors and fractures.
The study included 922 individuals (SSc patients, n = 154; OA patients, n = 768). Eighty-seven percent were female, with a mean age of 57.8 years. Fifty-one patients developed at least 1 fracture during a median of 4.2 years (0.5-22.0 years) of follow-up. Patients with SSc had more frequent fractures compared to OA comparators (hazard ratio [HR] 2.38 [95% confidence interval (95% CI) 1.47-3.83]). Among patients with SSc, a higher Rheumatic Disease Comorbidity Index score (HR 1.45 [95% CI 1.20-1.75]) and a higher Health Assessment Questionnaire disability index score (HR 3.83 [95% CI 2.12-6.93]) were associated with more fractures. Diabetes mellitus (HR 5.89 [95% CI 2.51-13.82]) and renal disease (HR 2.43 [95% CI 1.10-5.37]) were independently associated with fracture among SSc patients relative to SSc patients without these comorbidities.
Our findings highlight factors associated with fracture among patients with SSc. Disability as measured by the HAQ DI is a particularly strong indicator of fracture rate in SSc. Improving SSc patients' functional status, where possible, may lead to better long-term outcomes.
系统性硬化症(SSc)与疾病并发症和相关药物导致的多种特定骨折风险因素有关。本研究旨在检查大型美国队列中 SSc 相关临床特征与骨折发生率之间的关系。
纳入了 FORWARD 中的 SSc 参与者,该数据库是国家风湿病数据库(1998-2019 年)。还纳入了来自同一数据库的骨关节炎(OA)年龄和性别匹配的个体作为对照。主要终点是自我报告的主要骨质疏松性骨折。使用 Cox 比例风险模型研究了危险因素与骨折之间的关系。
研究纳入了 922 名个体(SSc 患者 154 名;OA 患者 768 名)。87%为女性,平均年龄为 57.8 岁。在中位 4.2 年(0.5-22.0 年)的随访期间,有 51 名患者发生了至少 1 次骨折。与 OA 对照组相比,SSc 患者的骨折发生率更高(风险比 [HR] 2.38 [95%置信区间(95%CI)1.47-3.83])。在 SSc 患者中,较高的风湿病合并症指数评分(HR 1.45 [95%CI 1.20-1.75])和较高的健康评估问卷残疾指数评分(HR 3.83 [95%CI 2.12-6.93])与更多骨折相关。与无这些合并症的 SSc 患者相比,糖尿病(HR 5.89 [95%CI 2.51-13.82])和肾脏疾病(HR 2.43 [95%CI 1.10-5.37])与 SSc 患者的骨折独立相关。
我们的研究结果强调了 SSc 患者骨折相关的因素。HAQ DI 测量的残疾是 SSc 骨折率的一个特别强的指标。尽可能改善 SSc 患者的功能状态可能会带来更好的长期结局。